Stomach Neoplasms: all 2,914 studies
Page 3 of 30. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.
- Recurrence After Gastric and Intestinal Polyp ResectionNot yet recruitingNCT07314554
- Clinical Efficacy of Adebrelimab With or Without Apatinib Mesilate and SOX Neoadjuvant Therapy in Locally Advanced Gastric CancerNot yet recruitingNCT07314203Phase 3
- Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric CancerRecruitingNCT07313579
- Esomeprazole Plus Sucralfate for Post-ESD Ulcer HealingNot yet recruitingNCT07312370Phase 4
- SHR-1701 + Rivoceranib (± SHR-2554) in Advanced GC After First-Line Immunotherapy FailureRecruitingNCT07311408Phase 2
- Robotic Gastrectomy With 5th ArmRecruitingNCT07310888Not applicable
- Adebrelimab Combined With Famitinib and Irinotecan in Advanced Gastric Cancer After Failure of First-Line TherapyRecruitingNCT07309185Phase 2
- High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea PatientsRecruitingNCT07307560Not applicable
- Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal MetastasisRecruitingNCT07304271Phase 3
- Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant TumorsRecruitingNCT07301814
- Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic LeakRecruitingNCT07295236
- Sentinel Node Resection With or Without LECS After Noncurative ESD for EGCNot yet recruitingNCT07295002Not applicable
- Novel Humanized Ferritin-Based NIR Fluorescent Probe for Identifying Sentinel Lymph Node Metastasis in Early Gastric CancerRecruitingNCT07294638
- Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment DelaysRecruitingNCT07283939Not applicable
- Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ AdenocarcinomaRecruitingNCT07277439Phase 2
- Novel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric TissueNot yet recruitingNCT07276854
- Minimal Residual Disease in Solid MalignanciesNot yet recruitingNCT07268469Not applicable
- The Efficacy and Safety of Laparoscopic Proximal Gastrectomy With LPG-tbROSF Versus LTG for Localized Proximal Gastric Cancer.Not yet recruitingNCT07260461Not applicable
- Distribution Characteristics of Helicobacter PyloriRecruitingNCT07253948
- AI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CTRecruitingNCT07250347
- Premedication With N-acetylcysteine and Simethicone to Improve Mucosal Visualization in Elective Upper EndoscopyRecruitingNCT07245095Phase 2
- Detection of Minimal Residual Disease Using Exosomal miRNA Distant Metastasis MarkersRecruitingNCT07243015
- Single-port Robotic Radical Gastrectomy for Gastric CancerRecruitingNCT07237126Not applicable
- Prevalence of H. Pylori in Stomach Cancers in the West IndiesRecruitingNCT07233447
- A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic CancerRecruitingNCT07227168Phase 1
- A Noninvasive and Screening miRNA Signature for Gastrointestinal CancerRecruitingNCT07224750
- A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)RecruitingNCT07221149Phase 2/3
- Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)RecruitingNCT07219238Phase 2/3
- A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Enrolling by invitationNCT07218003Phase 1
- Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.RecruitingNCT07217704Phase 3
- A Study of LY4337713 in Participants With FAP-Positive Solid TumorsRecruitingNCT07213791Phase 1
- The Safety and Clinical Efficacy of RAK Cell Therapy in Late-stage Gastric Cancer: A Randomized Controlled TrialRecruitingNCT07212933Phase 2
- Peri-habilitation for Patients With Gastric CancerNot yet recruitingNCT07201857Not applicable
- Conversion Therapy With RC48, Sintilimab, and SOX for HER2 1+/2+ Unresectable Gastric CancerRecruitingNCT07194005Phase 2
- Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gastric CancerNot yet recruitingNCT07183358Not applicable
- The Possible Range of No.4sb Lymph Node Dissection of Locally Advanced Distal Gastric CancerRecruitingNCT07183150
- CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid TumorsRecruitingNCT07179692Phase 1
- Temporal Transformation Mechanism and Intervention Strategies of Frail-related Dietary Behaviors in Older Gastric Cancer SurvivorsEnrolling by invitationNCT07176455
- Zanidatamab in Combination With Pembrolizumab and Chemotherapy in HER2 and PD-L1 Positive Metastatic Gastroesophageal Adenocarcinoma (GEA) PatientsRecruitingNCT07176312Phase 2
- Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese PatientsRecruitingNCT07175155Not applicable
- Clinical Application of PET Imaging Targeting GPA33 in Malignant TumorsNot yet recruitingNCT07172503Not applicable
- Safety and Efficacy of NK510 to Treat Gastric Cancer and Colorectal CancerRecruitingNCT07166263Early Phase 1
- Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)RecruitingNCT07165847Phase 2
- Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)RecruitingNCT07161479Not applicable
- Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid TumorsRecruitingNCT07151040Phase 1/2
- Lenvatinib in Combination With Nivolumab Plus Chemotherapy in Metastatic Gastric Cancer Patients With Malignant AscitesRecruitingNCT07149090Phase 1/2
- Safety Comparison of Total Laparoscopic Proximal Gastrectomy With or Without Preservation of the Celiac Branch of the Vagus Nerve for Early Upper Gastric Cancer: A Randomized Controlled Clinical TrialRecruitingNCT07142122Not applicable
- The Efficacy and Safety of Iparomlimab/Tuvonralimab (Anti PD-1/CTLA-4) Combined With Albumin-bound Paclitaxel in Second-line Treatment of Patients With Advanced Gastric/Gastroesophageal Junction AdenocarcinomaNot yet recruitingNCT07139587Not applicable
- The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing GastrectomyRecruitingNCT07139418
- Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue TreatmentRecruitingNCT07139366Phase 4
- INTERACT Stomach-IIRecruitingNCT07133490Phase 2
- Intraoperative Imaging of Gastrointestinal Malignancies Using Pafolacianine (CYTALUX™)RecruitingNCT07124351Phase 4
- Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer SurgeryRecruitingNCT07119463Phase 2
- Feasibility and Safety of Laparoscopic Purse-string Suture Clamp and Multi-functional Seal Cap for Totally Laparoscopic Radical Total GastrectomyNot yet recruitingNCT07117812Not applicable
- A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid TumorsRecruitingNCT07115043Phase 1/2
- A Study of LY4257496 in Participants With Cancer (OMNIRAY)RecruitingNCT07114601Phase 1
- A Trial of Adebrelimab Plus (SHR-A1811/SHR-A1904 With Chemotherapy) or SHR-8068 as Treatment for Gastric/GEJ CancerRecruitingNCT07110571Phase 2
- Detection of Upper Gastrointestinal Tumour Depth and Demarcation Using Systemic Administration of Indocyanine Green During Endoscopic Submucosal DissectionRecruitingNCT07108855Phase 1/2
- Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Junction AdenocarcinomaRecruitingNCT07102901Phase 2
- Total Neoadjuvant Therapy With Short Course Radiation Therapy in Gastric CancerNot yet recruitingNCT07101666Phase 2
- Acupuncture Combined With Chemotherapy for Gastric Cancer After SurgeryNot yet recruitingNCT07098949Not applicable
- Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric CancerRecruitingNCT07098026Not applicable
- Screening and Validation of Serum Protein Biomarkers for Early Diagnosis of Gastric CancerNot yet recruitingNCT07096752
- Comparison of the Sensitivity of pCLE and Pathological Biopsy Before ESDNot yet recruitingNCT07088744
- Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric CancerNot yet recruitingNCT07085273Phase 2
- Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Gastric Cancer：MetBio-GCRecruitingNCT07076979
- Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment DisorderRecruitingNCT07072728Phase 2
- Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEARecruitingNCT07070466Phase 2
- A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsRecruitingNCT07070232Phase 1/2
- The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor MicroenvironmentRecruitingNCT07069842
- A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal AdenocarcinomaRecruitingNCT07069712Phase 2
- Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical TrialRecruitingNCT07068607Phase 4
- Clinical Evaluation of GRAPE Model for Gastric Cancer ScreeningRecruitingNCT07067983
- A Study of MRG007 (ARR-217) in Patients With Advanced Solid TumorsRecruitingNCT07066657Phase 1
- Distance-Based Exercise to Preserve Function and Prevent DisabilityRecruitingNCT07059884Not applicable
- A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric AdenocarcinomaRecruitingNCT07059299Phase 1
- Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion ImmunochemotherapyRecruitingNCT07056010Not applicable
- Omega-3 Supplementation and Immunotherapy in Gastric Cancer: A Phase II TrialNot yet recruitingNCT07050524Phase 2
- Explainable Machine Learning for Predicting Early Gastric CancerEnrolling by invitationNCT07047937
- Phase II Study of QL1706 Combined With Paclitaxel and Bevacizumab for Second-Line Immune Rechallenge in Gastric CancerNot yet recruitingNCT07045805Phase 2
- The Application of 18F-G1 PET/CT Targeting Granzyme B in the Pan-cancer ImmunotherapyRecruitingNCT07039474
- Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis TechniquesRecruitingNCT07035587
- A Cohort Study of Mobile Capsule Gastroscopy for Gastric Pathologies ScreeningRecruitingNCT07032961
- Post-operative Monitoring of Gastric CancerRecruitingNCT07026240
- IBI343 Combined With Sintilimab Plus Chemotherapy in Gastric CancerRecruitingNCT07025889Phase 1/2
- The Exploration of Novel Radionuclide-labeled HER2-targeting Antibodies in the Diagnosis of HER2-positive MalignanciesEnrolling by invitationNCT07023861Early Phase 1
- PET Image Exploration of 89Zr-labeled Antibody Fragments Targeting HER2 in Patients With Malignant TumorsEnrolling by invitationNCT07023848Early Phase 1
- [18F]F-FAPI PET/CT and Laparoscopy in Staging Advanced Gastric CancerRecruitingNCT07018661Phase 2/3
- Neoadjuvant Nab-Paclitaxel Plus Oxaliplatin, S-1, and Sintilimab in Early-Onset Resectable Gastric CancerNot yet recruitingNCT07018063Phase 2
- Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric CancerRecruitingNCT07007182Phase 2
- Correlation of Psychological Distress and Immune Checkpoint Inhibitors in Gastric CancerRecruitingNCT07003334
- Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal TumorsRecruitingNCT07001592Phase 1
- Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric AdenocarcinomaRecruitingNCT07000253Phase 2
- A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory CarcinomasRecruitingNCT06999187Phase 1
- JSKN003 Combined Treatment of HER2-positive Gastric CancerNot yet recruitingNCT06998771Phase 2
- The Vanguard Study: Testing a New Way to Screen for CancerRecruitingNCT06995898Not applicable
- DESI - Düsseldorfer ESD StudyEnrolling by invitationNCT06993402
- DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET DysregulationsRecruitingNCT06988475Phase 2/3
- Effectiveness of ERAS on Postoperative Recovery After Minimally Invasive GastrectomyRecruitingNCT06984952Not applicable
- Node-Sparing Short-Course Radiotherapy Plus First-Line Therapy and PD-1 Inhibitor in Unresectable/Metastastic pMMR/MSS Gastric Cancer (MODIFI-GC)Not yet recruitingNCT06980389Phase 2